Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

NCT01907763 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: SOTB07 200mg
DRUG: SOTB07 400mg
DRUG: SOTB 200mg placebo
DRUG: SOTB 400mg placebo

Sponsor

SK Chemicals Co., Ltd.